Mark H. Greene

25.4k citations

198 papers · 9.6k indexed · 1 hit paper · h-index 49

Impact in

Oncology top 0.5%
- Cutaneous Melanoma Detection and Management
Dermatology top 0.2%

Papers in

Reproductive Medicine 31
- Ovarian cancer diagnosis and treatment 22
Genetics 72
- BRCA gene mutations in cancer 45
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities 15

Co-authors: Wallace H. Clark David E. Elder Philip S. Rosenberg Joseph F. Fraumeni Blanche P. Alter DuPont Guerry Jennifer T. Loud Martin N. Epstein
Journals: Cancer (10 papers)Cancer Epidemiology Biomarkers & Prevention (8 papers)International Journal of Cancer (8 papers)JNCI Journal of the National Cancer Institute (7 papers)New England Journal of Medicine (5 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Mark H. Greene

196 papers receiving 9.0k citations

Hit Papers

align trajectories log scale

A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma 1984 · 716 citations

Peers

Countries citing papers authored by Mark H. Greene

Since Specialization

Citations

This map shows the geographic impact of Mark H. Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Greene more than expected).

Fields of papers citing papers by Mark H. Greene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark H. Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Greene. The network helps show where Mark H. Greene may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark H. Greene, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark H. Greene Line = papers co-authored together Mark H. Greene links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study American Journal of Obstetrics and Gynecology ·L. Phuong, Austin Miller, Amanda Black, Roni T. Falk, John F. Boggess, Katherine Tucker, Ashley Stuckey, Gustavo C. Rodriguez, Cheung Wong, Thomas Amatruda, Débora Salatino Palomares, Susan C. Modesitt, S. Diane Yamada, Kristin Bixel, Gretchen Glaser, Peter G. Rose, Mark H. Greene, Mark E. Sherman	2022	3
2	Embodied risk for families with Li-Fraumeni syndrome: Like electricity through my body Social Science & Medicine ·Allison Werner‐Lin, Daniel Enrique Restrepo-Reyes, Jennifer L. Young, Alaa Atteya, Shana L. Merrill, Mark H. Greene, Payal P. Khincha	2022	5
3	Genetically Inferred Telomere Length and Testicular Germ Cell Tumor Risk Cancer Epidemiology Biomarkers & Prevention ·Derek W. Brown, Qing Lan, Nathaniel Rothman, John Pluta, Kristian Almstrup, Marlene Dalgaard, Mark H. Greene, Tom Grotmol, Chey Loveday, Stephen M. Schwartz, Clare Turnbull, Fredrik Wiklund, Peter A. Kanetsky, Katherine L. Nathanson, Katherine A. McGlynn, Mitchell J. Machiela	2021	3
4	Waiting and “weighted down”: the challenge of anticipatory loss for individuals and families with Li-Fraumeni Syndrome Familial Cancer ·Allison Werner‐Lin, Jennifer L. Young, Alaa Atteya, Shana L. Merrill, L Barbakadze, Mark H. Greene, Payal P. Khincha	2020	16
5	Diabetes, metformin and cancer risk in myotonic dystrophy type I International Journal of Cancer ·Rotana Alsaggaf, Ruth M. Pfeiffer, Youjin Wang, Diane Marie M. St. George, Min Zhan, Kathryn R. Wagner, Sania Amr, Mark H. Greene, Shahinaz M. Gadalla	2019	11
6	Factors Associated With Deciding Between Risk-Reducing Salpingo-oophorectomy and Ovarian Cancer Screening Among High-Risk Women Enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group Study Obstetrical & Gynecological Survey ·iandmyself20, Marion Piedmonte, Paul K. J. Han, Richard P. Moser, Joan L. Walker, Gustavo C. Rodriguez, John F. Boggess, Thomas Rutherford, Oliver Zivanovic, David E. Cohn, J.T. Thigpen, Robert M. Wenham, Michael Friedländer, Chad A. Hamilton, Jamie N. Bakkum‐Gamez, Alexander Olawaiye, Martee L. Hensley, Mark H. Greene, Helen Huang, Lari Wenzel	2017	1
7	Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink International Journal of Cancer ·Youjin Wang, Ruth M. Pfeiffer, Rotana Alsaggaf, Wilhelmine Meeraus, Julia C. Gage, Lesley Anderson, Renée C. Bremer, Nikoletta Nikolenko, Hanns Lochmüller, Mark H. Greene, Shahinaz M. Gadalla	2017	30
8	Research participant interest in primary, secondary, and incidental genomic findings Genetics in Medicine ·Jennifer T. Loud, Renée C. Bremer, L. Phuong, June A. Peters, Neelam Giri, Douglas R. Stewart, Mark H. Greene, Blanche P. Alter, Sharon A. Savage	2016	20
9	In Their Own Words: Treating Very Young BRCA1/2 Mutation-Positive Women with Care and Caution PLoS ONE ·Lindsey Hoskins, Allison Werner‐Lin, Mark H. Greene	2014	27
10	Correlates of tumor development in patients with myotonic dystrophy Journal of Neurology ·F C Wilkinson, Richard T. Moxley, James E. Hilbert, William B. Martens, Sieghart Döhring, Mark H. Greene, Shahinaz M. Gadalla	2012	36
11	An anthropomorphic phantom for quantitative evaluation of breast MRI Medical Physics ·Melanie Freed, Jacco A. de Zwart, Jennifer T. Loud, Riham H. El Khouli, Kyle J. Myers, Mark H. Greene, Jeff H. Duyn, Aldo Badano	2011	36
12	Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma International Journal of Cancer ·Ying Gao, Hormuzd A. Katki, Barry I. Graubard, Michaël Pollak, Michael J. Martin, Yuzhen Tao, Robert E. Schoen, Timothy R. Church, Richard B. Hayes, Mark H. Greene, Sonja I. Berndt	2011	48
13	Prevalence of Family History of Breast, Colorectal, Prostate, and Lung Cancer in a Population-Based Study Public Health Genomics ·Phuong Mai, Louise Wideroff, Mark H. Greene, Barry I. Graubard	2010	26
14	Coherence and Completeness of Population-based Family Cancer Reports Cancer Epidemiology Biomarkers & Prevention ·Louise Wideroff, Pratik M. Bezalwar, Mark H. Greene, Marsha Dunn, Timothy S. McNeel, Phuong Mai, Gordon Willis, Lou Gonsalves, Michael Martin, Barry I. Graubard	2010	20
15	Functional Phosphodiesterase 11A Mutations May Modify the Risk of Familial and Bilateral Testicular Germ Cell Tumors Cancer Research ·Anélia Horvath, Larissa A. Korde, Mark H. Greene, Rossella Libé, Inna Smolianova, Fábio R. Faucz, Marie Laure Raffin‐Sanson, Kit Man Tsang, Limor Drori-Herishanu, Hasanboy Umarov, Elaine F. Remmers, Furihata Tommy, Čhulālongkǭnmahāwitthayālai. Khana ʿAksǭnrasāt, J Greene, Maria Nesterova, Maria J. Merino, Jérôme Bertherat, Constantine A. Stratakis	2009	61
16	Sisters in hereditary breast and ovarian cancer families: communal coping, social integration, and psychological well‐being Psycho-Oncology ·Laura M. Koehly, June A. Peters, Natalia Kuhn, Lindsey Hoskins, Anne D. Letocha, Regina H. Kenen, Jennifer T. Loud, Mark H. Greene	2008	61
17	Exploratory study of the feasibility and utility of the colored eco‐genetic relationship map (CEGRM) in women at high genetic risk of developing breast cancer American Journal of Medical Genetics Part A ·June A. Peters, Regina H. Kenen, Ruthann M. Giusti, Jennifer T. Loud, 김영치, Mark H. Greene	2004	20
18	Desmoid tumors in familial adenomatous polyposis: a pilot project evaluating efficacy of treatment with pirfenidone The American Journal of Gastroenterology ·Noralane M. Lindor, Roger R. Dozois, Heidi Nelson, B. G. Wolff, Jess King, Lisa A. Boardman, Mark Wilson, Mark H. Greene, William E. Karnes, Ruben A. Mesa, Thomas R. Welch, J H Edmonson, Paul J. Limburg	2003	11
19	Papillary Renal Cell Carcinoma: Analysis of Germline Mutations in the MET Proto-Oncogene in a Clinic-Based Population Genetic Testing ·Noralane M. Lindor, Christopher Dechet, Mark H. Greene, Robert B. Jenkins, U.‐E Kalsoom, Amy L. Weaver, Marcia Wilson, Horst Zincke, Wanguo Liu	2001	29
20	Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Ronald Reimer, Wallace H. Clark, Mark H. Greene, Valram Delin, Joseph F. Fraumeni	1978	167

About Mark H. Greene

Mark H. Greene is a scholar working on Reproductive Medicine, Genetics, Oncology, Toxicology and Pathology and Forensic Medicine, having authored 198 papers that have together received 9.6k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (45 papers), Testicular diseases and treatments (32 papers), Cutaneous Melanoma Detection and Management (25 papers), Ovarian cancer diagnosis and treatment (22 papers), Family Support in Illness (15 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (15 papers), Genetic Neurodegenerative Diseases (14 papers) and DNA Repair Mechanisms (13 papers). The work is most often cited by research in Oncology (3.5k citations), Dermatology (968 citations), Reproductive Medicine (860 citations), Cancer Research (1.3k citations) and Genetics (2.3k citations). Mark H. Greene has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Wallace H. Clark, David E. Elder, Philip S. Rosenberg, Joseph F. Fraumeni, Blanche P. Alter, DuPont Guerry, Jennifer T. Loud, Martin N. Epstein, June A. Peters and Lindsey Hoskins. Their work appears in journals such as Cancer, Cancer Epidemiology Biomarkers & Prevention, International Journal of Cancer, JNCI Journal of the National Cancer Institute and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact